These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

635 related items for PubMed ID: 21549187

  • 1. Oil based nanocarrier for improved oral delivery of silymarin: In vitro and in vivo studies.
    Parveen R, Baboota S, Ali J, Ahuja A, Vasudev SS, Ahmad S.
    Int J Pharm; 2011 Jul 15; 413(1-2):245-53. PubMed ID: 21549187
    [Abstract] [Full Text] [Related]

  • 2. Development and bioavailability assessment of ramipril nanoemulsion formulation.
    Shafiq S, Shakeel F, Talegaonkar S, Ahmad FJ, Khar RK, Ali M.
    Eur J Pharm Biopharm; 2007 May 15; 66(2):227-43. PubMed ID: 17127045
    [Abstract] [Full Text] [Related]

  • 3. Preparation of silymarin proliposome: a new way to increase oral bioavailability of silymarin in beagle dogs.
    Yan-yu X, Yun-mei S, Zhi-peng C, Qi-neng P.
    Int J Pharm; 2006 Aug 17; 319(1-2):162-8. PubMed ID: 16687221
    [Abstract] [Full Text] [Related]

  • 4. Nanocarrier for the enhanced bioavailability of a cardiovascular agent: in vitro, pharmacodynamic, pharmacokinetic and stability assessment.
    Bali V, Ali M, Ali J.
    Int J Pharm; 2011 Jan 17; 403(1-2):46-56. PubMed ID: 20969935
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Potential of nanoemulsions for intravenous delivery of rifampicin.
    Ahmed M, Ramadan W, Rambhu D, Shakeel F.
    Pharmazie; 2008 Nov 17; 63(11):806-11. PubMed ID: 19069240
    [Abstract] [Full Text] [Related]

  • 7. Enhancement of the in-vitro dissolution and in-vivo oral bioavailability of silymarin from liquid-filled hard gelatin capsules of semisolid dispersion using Gelucire 44/14 as a carrier.
    Hussein A, El-Menshawe S, Afouna M.
    Pharmazie; 2012 Mar 17; 67(3):209-14. PubMed ID: 22530301
    [Abstract] [Full Text] [Related]

  • 8. Formulation optimization of self-emulsifying preparations of puerarin through self-emulsifying performances evaluation in vitro and pharmacokinetic studies in vivo.
    Quan DQ, Xu GX.
    Yao Xue Xue Bao; 2007 Aug 17; 42(8):886-91. PubMed ID: 17944241
    [Abstract] [Full Text] [Related]

  • 9. Anticancer efficacy, tissue distribution and blood pharmacokinetics of surface modified nanocarrier containing melphalan.
    Rajpoot P, Bali V, Pathak K.
    Int J Pharm; 2012 Apr 15; 426(1-2):219-230. PubMed ID: 22301424
    [Abstract] [Full Text] [Related]

  • 10. Effects of silymarin nanoemulsion against carbon tetrachloride-induced hepatic damage.
    Parveen R, Baboota S, Ali J, Ahuja A, Vasudev SS, Ahmad S.
    Arch Pharm Res; 2011 May 15; 34(5):767-74. PubMed ID: 21656362
    [Abstract] [Full Text] [Related]

  • 11. Enhanced bioavailability of silymarin by self-microemulsifying drug delivery system.
    Wu W, Wang Y, Que L.
    Eur J Pharm Biopharm; 2006 Jul 15; 63(3):288-94. PubMed ID: 16527467
    [Abstract] [Full Text] [Related]

  • 12. Enhanced oral bioavailability of Coenzyme Q10 by self-emulsifying drug delivery systems.
    Balakrishnan P, Lee BJ, Oh DH, Kim JO, Lee YI, Kim DD, Jee JP, Lee YB, Woo JS, Yong CS, Choi HG.
    Int J Pharm; 2009 Jun 05; 374(1-2):66-72. PubMed ID: 19446761
    [Abstract] [Full Text] [Related]

  • 13. Transdermal delivery of anticancer drug caffeine from water-in-oil nanoemulsions.
    Shakeel F, Ramadan W.
    Colloids Surf B Biointerfaces; 2010 Jan 01; 75(1):356-62. PubMed ID: 19783127
    [Abstract] [Full Text] [Related]

  • 14. Reassessing bioavailability of silymarin.
    Javed S, Kohli K, Ali M.
    Altern Med Rev; 2011 Sep 01; 16(3):239-49. PubMed ID: 21951025
    [Abstract] [Full Text] [Related]

  • 15. Self-nanoemulsifying drug delivery system (SNEDDS) of the poorly water-soluble grapefruit flavonoid Naringenin: design, characterization, in vitro and in vivo evaluation.
    Khan AW, Kotta S, Ansari SH, Sharma RK, Ali J.
    Drug Deliv; 2015 Sep 01; 22(4):552-61. PubMed ID: 24512268
    [Abstract] [Full Text] [Related]

  • 16. Formulation and biopharmaceutical evaluation of silymarin using SMEDDS.
    Woo JS, Kim TS, Park JH, Chi SC.
    Arch Pharm Res; 2007 Jan 01; 30(1):82-9. PubMed ID: 17328246
    [Abstract] [Full Text] [Related]

  • 17. Self-nanoemulsifying drug delivery system (SNEDDS) for oral delivery of protein drugs: III. In vivo oral absorption study.
    Rao SV, Yajurvedi K, Shao J.
    Int J Pharm; 2008 Oct 01; 362(1-2):16-9. PubMed ID: 18650037
    [Abstract] [Full Text] [Related]

  • 18. Silymarin nanoemulsion against human hepatocellular carcinoma: development and optimization.
    Ahmad U, Akhtar J, Singh SP, Ahmad FJ, Siddiqui S.
    Artif Cells Nanomed Biotechnol; 2018 Mar 01; 46(2):231-241. PubMed ID: 28503949
    [Abstract] [Full Text] [Related]

  • 19. Self nanoemulsifying drug delivery system (SNEDDS) of rosuvastatin calcium: design, formulation, bioavailability and pharmacokinetic evaluation.
    Balakumar K, Raghavan CV, selvan NT, prasad RH, Abdu S.
    Colloids Surf B Biointerfaces; 2013 Dec 01; 112():337-43. PubMed ID: 24012665
    [Abstract] [Full Text] [Related]

  • 20. Nanoemulsion strategy for olmesartan medoxomil improves oral absorption and extended antihypertensive activity in hypertensive rats.
    Gorain B, Choudhury H, Kundu A, Sarkar L, Karmakar S, Jaisankar P, Pal TK.
    Colloids Surf B Biointerfaces; 2014 Mar 01; 115():286-94. PubMed ID: 24388859
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.